HomeOpen Access NewsOAG 016 - November 2017

OAG 016 - November 2017

What’s in an aggregate? Therapeutic intervention in Huntington’s

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention

Cardiology: Prevention is better than cure

Joep Perk from the European Society of Cardiology talks about methods of preventing cardiovascular diseases and research into cures

Crime, terrorist threat, and inappropriate public behaviour

Anton Pieterse, Managing Director of physical security equipment provider Safetell specialising in counter-terror solutions, comments on terrorist threat

Europe can lead the way to a cure for asthma

Susanna Palkonen of the European Federation of Allergies and Airways Diseases Patients’ Associations underlines research around asthma in Europe today

Human-centred approach to data leads the way to a smarter digital age

Markus Hautala and Antti Kettunen at Tieto reveal how Blockchain has rapidly emerged as one of the disrupting technologies of the digital age

Ambrosus: Digitalising the Global Trade with Blockchain

Angel Versetti, CEO of Ambrosus discusses the world’s first blockchain ecosystem for supply chains and global trade

Understanding evolution, past and future

Dr Virginie Courtier-Orgogozo from CNRS details her work on fruit flies, which examines the intricate link between genes and visible traits of living creatures

Blockchain: what is in it for the European economy?

Benoît Abeloos, Policy Officer at the European Commission gives a compelling glimpse into how virtual currency could affect the economy

Newborn brain injury – innovations in early diagnostics

A new direction in the monitoring of brain injury in babies, pioneered by a team of physicists, engineers and doctors in University College London (UCL) and University College London Hospitals (UCLH)

Malaria Drug Resistance: Evolving and Moving in the Mekong Region

Professor of Chemistry at Portland State University, David H Peyton. PhD turns the spotlight on malaria drug resistance in the Mekong region

Entrepreneurial opportunities in fusion energy development

Dr. Y. C. Francis Thio and Dr. F. Douglas Witherspoon turn the spotlight on how lower-cost pathways to fusion energy can be attractive to investors

The future of blockchain: Learning from things yet to happen

Disruption, pivot, 10X change – these words describe current strategic interest in everything new, but how do we decide the future of blockchain?

Pre-disposition to chronic inflammatory lung diseases

Michael Roth, Research Group Leader, Pulmonary Cell Research at University Hospital Basel & University Basel sheds light on inflammatory lung diseases

The approval process of pesticides and the science behind it

Graeme Taylor, director of public affairs at European Crop Protection Association reveals the impact of technology on the pesticide approval process

Looking forward to the future of chemistry

Angela K. Wilson and Carol A. Bessel from the Division of Chemistry (CHE) at the National NSF provide a fascinating insight into the future of chemistry

University of California scientists target glioblastoma with stem cell research

Targeted stem cell research at the University of California, Irvine could one day eradicate glioblastoma brain tumours, explains John Lowengrub

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML)

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research explores the current progress in Acute Myeloid Leukaemia (AML)

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders